What BPC-157 and TB-500 are
BPC-157 is a synthetic chain of 15 amino acids, based on part of a larger protein that researchers at the University of Zagreb in Croatia reported finding in human gastric juice. It is made in a lab, and there is little evidence that this exact fragment circulates in the body on its own.
TB-500 is a name for a synthetic peptide linked to thymosin beta-4, a natural protein found in almost every cell, with especially high levels in platelets and white blood cells. The name is used loosely, as the next section explains.
Thymosin beta-4 vs the TB-500 fragment
Thymosin beta-4 is the full protein, 43 amino acids long, and it is the molecule tested in small human trials. In laboratory analyses, TB-500 usually refers to a 7-amino-acid piece of it, amino acids 17 to 23, often with an acetyl group added at one end. That piece is the part that binds actin. Some products sold as TB-500 are the full-length protein instead, and labels often do not say which.
Research on one form should not be assumed to apply to another, yet most claims about TB-500 are borrowed from thymosin beta-4 studies. A little lab work suggests the actin-binding piece alone can promote blood vessel cell migration, but whether the fragment acts like the whole protein in people has not been shown. The first four amino acids form Ac-SDKP, a separate peptide studied for anti-fibrotic effects.
How they are thought to work
The two appear to act through different routes in lab and animal studies. BPC-157 has been linked to angiogenesis, the growth of new small blood vessels, partly through the VEGF receptor pathway, and to the nitric oxide system that helps control blood flow. Thymosin beta-4 holds single units of actin in reserve, which helps cells build or break down their internal scaffolding and move toward injured areas, and it has been linked to lower levels of some inflammatory signals. For both, these are proposed mechanisms measured mostly in rats or cells, not settled human biology.
What the research shows
So BPC-157 has more direct research on itself, though mostly from one group and almost all in rats. TB-500 has little research of its own, but its parent protein has a few small human trials, mainly on skin and eyes. Neither has controlled human studies for the muscle and tendon injuries people discuss most.
- BPC-157 in animals
- Rat studies reported faster, better organized repair of damaged tendons and ligaments, better muscle recovery, and less damage to the stomach and bowel lining.
- BPC-157 in people
- Only a few small reports without control groups, plus an early clinical program for bowel disease with little published detail.
- Thymosin beta-4 in animals
- Rat and mouse studies looked at skin wounds, heart attack, brain injury and hair growth, with encouraging early results.
- Thymosin beta-4 in people
- Small trials of a skin gel for chronic ulcers and of eye drops for dry eye and a rare corneal disorder had mixed results.
- TB-500 itself
- Very little research of its own, and no published human trials of the fragment.
Side effects and cautions
Neither peptide has large human safety studies. Animal safety studies of BPC-157 reported few toxic effects, and small human trials of full-length thymosin beta-4 reported it was generally well tolerated, but neither finding covers the TB-500 fragment or long-term use. Effects people describe online, such as local irritation, headache, tiredness or water retention, are anecdotal. Anyone with health questions should talk to a qualified clinician.
- Cancer history
- BPC-157 appears to promote blood vessel growth, and higher thymosin beta-4 levels have been linked with tumor growth and spread in some lab studies. Both are theoretical concerns for people with current or past cancer.
- Product identity
- Products can differ from their labels in content or purity, and TB-500 labels may not say whether the fragment or the full protein is inside.
- Pregnancy and long-term use
- There are no safety data in pregnancy, and no study has followed people using either over time.
- Dosage
- The BPC-157 profile and the TB-500 profile each have a dosage section.
Why they are often paired
Because they seem to act at different points in repair, one tied to blood vessel signaling and the other to how cells move and organize, the two are often discussed together or premixed, sometimes under the nickname wolverine stack. That reasoning is plausible, but no published animal or human study has tested the pair. The BPC-157 + TB-500 profile covers the combination.
